CYTOKINE INDUCED KILLER (CIK) CELLS FOR CELL THERAPY OF ACUTE MYELOID LEUKEMIA (AML): IMPROVEMENT OF IMMUNE ACTIVITY BY EXPRESSION OF CD33-SPECIFIC CHIMERIC RECEPTORS (CAR)